Delivery Order SPE2DE24D0013-SPE2D625F83ML

Award Date 2/19/25
Potential Completion Date 3/5/25
Potential Value $2.2K
Federal Agency
Medical Supply Chain
Awardee
Cepheid
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The contract, valued at $5,440.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, Inc., a for-profit manufacturer of molecular diagnostic solutions specializing in advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and clinical testing. The contract, valued at $3,567.40, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These products and services are...
This federal contract award, valued at $14,448.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) and has no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $5,440.00 firm fixed-price delivery order contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has no set-aside designation. Cepheid holds several significant...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $2,040.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This award is not...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $4,080.00, is a firm fixed-price delivery order that provides the DLA with Cepheid's GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These products and services are used for detecting a variety of infectious diseases, including COVID-19, influenza, and respiratory...
This federal contract award, worth up to $204,000.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a firm fixed-price delivery order, with no set-aside designation. Cepheid will provide the agency with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions enable the rapid detection and diagnosis of various infectious diseases, including...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract, valued at $44,854.40, is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has no...
This federal contract award, valued at $10,200.00, was issued to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract does not have a set-aside designation....
This is a firm fixed-price delivery order federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA) with a total ceiling value of $3,465.00. The contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to support the detection of infectious diseases such as COVID-19, influenza, and other clinical conditions. The contract is not associated with a...
  • SPE2DE24D0013
    Indefinite Delivery Contract
  • SPE2DE24D0013-SPE2D625F83ML
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $2,244.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The products are intended to support the detection of infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and other clinical conditions for various federal agencies, including the Department of Veterans Affairs (VA) and Indian Health Service. The contract does not have a set-aside designation and is part of a larger Indefinite Delivery Vehicle (IDV) that enables continuous procurement of Cepheid's molecular diagnostic solutions by federal agencies. Cepheid has also received federal grant awards as a subrecipient, collaborating with academic institutions and other organizations on specialized research projects related to infectious disease diagnostics.

Generated 5/21/25, 10:00 AM